Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Effects of Bronchial Segmental Endotoxin Instillation in Humans

NCT02392442 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT02392442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Effects of Bronchial Segmental Endotoxin Instillation in Humans
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
June 18, 2015
Completion date
June 30, 2027
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung inflammation